curriculum vitae leonid poretsky, m.d. · faculty member for the following problem based learning...

CURRICULUM VITAE LEONIDPORETSKY,M.D.

6/5/2018 ADDRESS: Home: 1025FifthAvenue,#8ES NewYork,N.Y.10028

Business:NorthwellHealth–LenoxHillHospital100East77thStreetNewYork,N.Y.10075

TELEPHONE: (212)434-4972(office)DATEOFBIRTH: August7,1954PLACEOFBIRTH: Leningrad,Russia(USSR)CITIZENSHIP: UnitedStates,1985

ImmigratedtoU.S.A.in1979MEDICALSCHOOL:1971-1977 M.D.,CumLaude

FirstMedicalInstituteLeningrad,Russia(USSR)

CURRENTPOSITIONS: 2014–Present Chief,DivisionofEndocrinology AssociateChairman,DepartmentofMedicine NorthwellHealth–LenoxHillHospital NewYork,NewYork10075 ProfessorofMedicine DonaldandBarbaraZuckerSchoolofMedicineatHofstraNorthwell

PREVIOUSHOSPITALAPPOINTMENTS:2000–2014 InterimChairman,DepartmentofMedicine(2014) Chief,DivisionofEndocrinology&Metabolism(2000)

GeraldJ.FriedmanChairinEndocrinology(2004) ProgramDirector,FellowshipinEndocrinologyandMetabolism(2000) Director,GeraldJ.FriedmanDiabetesInstitute(2007) ResearchIntegrityOfficer(2012) MountSinaiBethIsrael NewYork,NewYork

2012–2014 Vice-ChairmanforResearch,DepartmentofMedicine MountSinaiBethIsrael NewYork,NewYork

LEONIDPORETSKY,M.D.

2

1995-2000 Director,DiabetesCenterAssociateDirector,GeneralClinicalResearchCenterProfessorofMedicineandGynecology(1999)NewYorkHospital/CornellMedicalCenterNewYork,NewYork

1989-1995 Chief,DivisionofEndocrinologyandMetabolism,

CabriniMedicalCenterNewYork,NewYork

1985-1989 Head,DiabetesSection

DivisionofEndocrinologyandMetabolismDepartmentofMedicineBethIsraelMedicalCenterNewYork,NewYork

1983-1985 FellowinEndocrinology,

BethIsraelHospitalBoston,Massachusetts

1983-1985 Physician(part-time),JoslinDiabetesCenter,Boston,Massachusetts

1982–1983 ChiefResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1980–1982 ResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1978-1979 Physician,MedicalEmergencyStation

Leningrad,Russia(USSR)1977-1978 Physician,

DepartmentofInternalMedicineStateHospitalNumber21Leningrad,Russia(USSR)

PREVIOUSMEDICALSCHOOLAPPOINTMENTS:2000-2014 ProfessorofMedicine,AlbertEinsteinCollegeofMedicine(2000)

ProfessorofMedicine,IcahnSchoolofMedicineatMountSinai(2014)1999-2000 ProfessorofMedicineandGynecology WeillMedicalCollegeofCornellUniversity NewYork,NewYork

LEONIDPORETSKY,M.D.

3

1995-1999 AssociateProfessorofMedicineandGynecologyCornellUniversityMedicalCollegeNewYork,NewYork

1990-1995 AssociateProfessorofMedicine

NewYorkMedicalCollegeValhalla,NewYork

1989-1990 AssociateProfessorofMedicine

Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork

1985-1989 AssistantProfessorofMedicine

Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork

POSTDOCTORALTRAINING:2003 MedicalInformaticsMBL/NLMCourseFellow

MarineBiologicalLaboratorySponsoredbytheNationalLibraryofMedicineWoodsHole,Massachusetts

1983-1985 ResearchFellowinMedicine,

HarvardMedicalSchool,CharlesA.DanaResearchInstituteandTheHarvard-ThorndikeLaboratory.FellowinEndocrinologyandDiabetes,Boston’sBeth IsraelHospital,with clinical duties atBrighamMedicalGroupandHarvardCommunityHealthPlan,Boston,Massachusetts

1982-1983 ChiefResident,

DepartmentofMedicine,ConeyIslandHospital,Brooklyn,NewYork

1980-1982 ResidentinMedicine,

ConeyIslandHospital,Brooklyn,NewYork

LICENSUREANDCERTIFICATION:1985 Diplomate

AmericanBoardofEndocrinologyandMetabolismCert.#90042

LEONIDPORETSKY,M.D.

4

1983 DiplomateAmericanBoardofInternalMedicineCert.#90042

1996 PennsylvaniaStateLicenseRegistration#MD-057239-L1983 NewYorkStateLicenseRegistration#155121-11983 MassachusettsLicenseRegistration#510421982 CaliforniaLicenseRegistration#A392571981 MarylandLicenseRegistration#D269361981 FLEXExaminationpassedJune,19811980 ECFMGCertificate#314376-6TEACHINGEXPERIENCE:2000-2014 Chief,DivisionofEndocrinologyandMetabolism,

BethIsraelMedicalCenter.Teachingmedicalstudents,residentsandfellows.

ProgramDirectorforthefellowshiptrainingprogram. 1995-2000 Director,DiabetesCenter,NewYorkHospital-

CornellMedicalCenter,NewYork,NYFacultyMember for the following problem based learning (PBL) courses: “HumanStructureandFunction”and“FromMoleculestoCells”.Preceptorforthetriplejumpexamination(2ndyearmedicalstudents).Writingquestionsforthepathophysiologyexamination (2nd year medical students). Lectures for medical students: “Type 1diabetes mellitus” and “Insulin and glucagon.” Endocrine grand rounds: “Role ofinsulin and insulin-like growth factors in ovarian function” and “Polycystic ovarysyndrome.” Medical grand rounds: “Syndromes of insulin resistance.” Teachingresidents and fellows in clinical setting (attending ward physician in internalmedicineandendocrinology;attendingphysicianintheendocrineclinicandhigh-riskpregnancy clinic). Member, Cornell University Medical College Department ofMedicine Postgraduate Education Advisory Committee and Update in MedicineCommittee.LecturesthroughoutNewYorkMetropolitanareaonthetopicofinsulinresistance (Columbia University, New York University School of Medicine, MountSinaiSchoolofMedicine,AlbertEinsteinCollegeofMedicine).

1989-1995 Chief,DivisionofEndocrinologyandMetabolism

CabriniMedicalCenter,NewYork,NYRoundswithhousestaffandmedicalstudentsin endocrinology& internalmedicine. Organizing endocrine conferences and boardreviewcoursesforresidents. Organizinginter-institutionalendocrinegrandrounds,(CabriniMedicalCenter,St.VincentMedicalCenter,RogosinInstitute). LecturingoninsulinreceptordisordersandendocrinologicalaspectsofAIDS.

LEONIDPORETSKY,M.D.

5

1985-1989 Head,DiabetesSectionBethIsraelMedicalCenter,NewYork,NYConducting rounds with housestaff and medical students; responsible for weeklyendocrine grand rounds and monthly research conferences. Lecturing on insulinreceptordisorders.

1983-1985 FellowinEndocrinologyandMetabolism,Boston’sBeth

IsraelHospitalandHarvardMedicalSchoolWhile on clinical service, supervised students and residents rotating through theservice; presented endocrine grand rounds on the following subjects: Lipoatrophicdiabetes;Insulinreceptorsinhealthanddisease;andInsulineffectsintheovary.

1982-1983 ChiefResident,DepartmentofMedicine,Coney IslandHospital,Brooklyn,NewYork

Teaching residents in a clinical setting; conducting daily MICU rounds and weeklyclinicalconferences.

1982-1983 Preceptor for Physical Diagnosis Course, Sophie Davis School of Biomedical

Education,CityUniversityofNewYork.1971-1977 Teachingbiologycourseforpremedicalstudents,

FirstMedicalInstitute,Leningrad,Russia(USSR).COMMITTEEMEMBERSHIPS:CommitteeonScholarlyActivities,MountSinaiBethIsrael,NewYork,NewYorkDepartmentofMedicineDivisionChiefs,MountSinaiBethIsrael,NewYork,NewYorkDiabetesCareEnhancementInitiativeCommittee,BethIsraelMedicalCenter,NewYork,NewYorkMAJORRESEARCHINTERESTS:Mechanismsof insulinandinsulin-likegrowthfactoractionintheovary;endocrinologicalaspectsofAIDS;clinicaloutcomesindiabetes.GrantSupport:2017-Ongoing ProjectDirector(LenoxHillHospital)–“Obesityasamultifactorialdisease:Energy metabolism,insulinresistance,microblomeandendoscopicbariatricintervention in human obesity” – NY State Department of Health, Empire Clinical Research

Program(ECRIP).Directcosts$698,8882017-Ongoing Site Principal Investigator – Sanofi: Sotagliflozin compared to empagliflozin and

placebo in patientswith type 2 diabeteswho have inadequate glycemic control onDipeptidyl Peptidase 4 Inhibitor (DPP4I)with orwithoutmetformin -amulticenterclinicaltrial.

LEONIDPORETSKY,M.D.

6

2017-Ongoing SitePrincipal Investigator–Sanofi: TheSCOREDTrial, a randomized,doubleblind,placebo-controlled, parallel-group, multicenter study to demonstrate the effects ofsotagliflozin on cardiovascular and renal events in patients with type 2 diabetes,cardiovascular risk factors and moderately impaired renal function, a multi-centerclinicaltrial.

2017-Ongoing Site Principal Investigator – Role of CAP1 in mediating resistin action in obesity-

inducedinsulinresistance.GeraldJ.andDorothyR.FriedmanNewYorkFoundationforMedicalResearch

2017–Ongoing SitePrincipalInvestigator-Novartis:APhaseIII,multi-center,randomized,double

blind,48weekstudywithaninitial12weekplacebo-controlledperiodtoevaluatethesafetyandefficacyofosilodrostatinpatientswithCushing’sdisease

2016–Ongoing SiteCo-Investigator(LenoxHillHospital);NIDDKGrantNumberUO1DK098245-03.

VitaminD and type 2 diabetes (D2d study). Principal Investigator: Anastassios G.Pittas,MD,TuftsUniversity.IRBNo.HS16-0144.

2015–Ongoing SitePrincipalInvestigator–“Theeffectofstructuredoutpatientdiabetesprogramon

hospitalreadmissionratesinpatientswithdiabetes”-NYStateDepartmentofHealth,EmpireClinicalResearchInvestigationProgram(ECRIP).Directcosts$150,000.00

2016–2017 SitePrincipalInvestigator-Sanofi:APhaseIVrandomized,open-label,parallelgroup

realworldpragmatictrialtoassesstheclinicalandhealthoutcomesofToujeocomparedtocommerciallyavailablebasalinsulinsforinitiationoftherapyininsulinnaïvepatientswithuncontrolledtype2diabetesmellitus.

2016–2017 SitePrincipalInvestigator-Novartis:Amulti-center,randomized,open-label,Phase

IVstudytoinvestigatethemanagementofpasireotide-inducedhyperglycemiawithincretinbasedtherapyorinsulininadultpatientswithCushing’sdiseaseoracromegaly.

2014 SatellitePrincipalInvestigator(BethIsrael);NIDDKGrantNumberNCT02017171. Preventing Early Renal Loss in Diabetes (PERL): A multicenterclinical trial of allopurinol to prevent GFR loss in type 1 diabetes. PrincipalInvestigator: Alessandro Doria,MD PhDMPH, Joslin Diabetes Center. Direct Cost:$315,850.00

2013–2014 Site Principal Investigator (Beth Israel); NIDDK Grant Number U01DK098245

(implementation phase). Vitamin D and type 2 diabetes (D2d study). PrincipalInvestigator:AnastassiosG.Pittas,MD,TuftsUniversity.DirectCost:$153,583.00.

2012–2013 SitePrincipal Investigator (Beth Israel); Genzyme Inc.,MountSinaiMedicalCenter.

Multi-center study of the effect of Sevelamer carbonate onmetabolic/inflammatory/reactive oxygen speciesmarkers in diabetes patientswithnephropathy. Principal Investigator: GaryStriker,MD,MountSinaiMedicalCenter.DirectCost:$119,844.00.

LEONIDPORETSKY,M.D.

7

2011–2013 Co-Investigator, NIH National Center for Minority Health and Health Disparities,Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities, AlbertEinsteinCollegeofMedicine. Activatingpeople fordiseaseprevention and lifestylechangethroughempowerment(APPLE).PrincipalInvestigator:AlisonKarasz,Ph.D.,AlbertEinsteinCollegeofMedicine.

2011-2012 Co-investigator;NIDDKGrantNumberU34DK091958(planningphase).VitaminDfor

preventionoftype2Diabetes(D2Dstudy).PrincipalInvestigator:AnastassiosPittas,MD,TuftsUniversity.DirectCost:$161,463.00.

2009–2014 Advisor; NIH #K07AT004570-01A2. Academic career development award in

Complementary and Alternative Medicine Research and Education. PrincipalInvestigator:BenjaminKligler,MD,MPH,BethIsraelMedicalCenter.

2009–2011 Co-investigator; Chinese American Medical Society and Chinese American

IndependentPracticeAssociationResearchFund.Geneticmarkersforincreasedriskof gestational diabetes in Chinese-Americans. Principal Investigator: Donna Seto-Young,Ph.D,BethIsraelMedicalCenter.

2011–2012 Site Principal Investigator; United Hospital Fund. Health coaches—assist patients

with diabetes in managing their illness and help them navigate the health caresystem.DirectCost:$37,830.00.

2009–2011 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYork

StateDepartmentofHealth.TheRoleofThiazolidinedionesinBoneMetabolism2008-2010 SitePrincipalInvestigator;Queens/SouthAsianActionforDiabetes

EducationProgramandTreatment(ADEPT),NewYorkStateHealthFoundation.DirectCost:$269,803.

2008–2010 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState

DepartmentofHealth.Effectsofexenatideinoverweightpatientswithpolycysticovarysyndrome(PCOS)androleofexenatideinhumanovarianregulation.

2008–2014 SitePrincipalInvestigator;Apilotrandomizedcontrolledtrialtoevaluatetheeffects

of education programs, including an interactive web site, on clinical outcomes inpatientswithdiabetes.GeraldJ.FriedmanDiabetesInstitute

2002–2014 SitePrincipal Investigator;GeraldJ.FriedmanFoundation. Receptormechanismsof

insulinandinsulin-likegrowthfactorsinovarianfunction.2004-2008 SitePrincipalInvestigator;Glaxo-SmithKline, Inc.Theeffectofthiazolidinedioneson

inflammatorymarkersandoutcomesinpatientsundergoingcoronaryarterybypassgraftsurgery.

2006–2008 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State

Department of Health. Administration of Vitamin D analog to new onset type 1diabetesmellituspatientstorestorepancreaticcellfunction

LEONIDPORETSKY,M.D.

8

2005–2007 Investigator/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState.Comparisonoftheeffectoforalcontraceptiveagents,spironolactone,metforminandrosiglitazone on plasma androgen levels and clinical manifestations ofhyperandrogenesiminwomenwithpolycysticovarysyndrome.

2004–2006 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.

VitaminDdeficiencyandinsulinresistance.2003–2005 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.

The use of intensive insulin therapy in diabetic and non-diabetic individualsundergoingcoronaryarterybypassgraftsurgery.

2002–2004 Site Principal Investigator; Pharmacia, Inc. Role of thiazolidinediones in the human

ovary.2000–2006 Site Principal Investigator (Beth Israel Medical Center); ADOPT trial; Glaxo-Smith-

Kline,Inc.2000–2005 Co-investigator;NIHR01-MH60563.DHEAeffectsonmoodinHIVpositivepatients.

PrincipalInvestigator:JudyRabkin,Ph.D.,ColumbiaUniversity.2000–2002 Site Principal Investigator; Singer/Hellman Award. Receptormechanisms of insulin

actioninthehumanovary.1998–2000 SitePrincipalInvestigator;NICHDR035618-01A1:Receptormechanismsof insulin-

likegrowthfactorIIactionintheovary.1999–2000 Co-Investigator;N01-HC-95184 (NHLBI-NIDDK)PreventionofCardiovascularDisease in

DiabetesMellitus.PrincipalInvestigator:J.ThomasBigger,M.D.,ColumbiaUniversity.1995–2000 Cornell University Medical College General Clinical Research Center, Associate Program

Director;NIHGrant#M01RR00047-35.1996–2000 Clinicaltrialofpioglitazoneindiabetes,Takeda,Inc.1997–2000 Combinationtrialofmetforminandsulfonureaindiabetes,Bristol-Myers,Inc.1987–1992 SitePrincipalInvestigator, NIH–Grant#R29-HD22738,RoleofInsulinandInsulin-like GrowthFactorsinOvarianFunction.1986–1988 SitePrincipalInvestigator,

UnitedParcelServiceResearchinMedicineAward;RoleofInsulininOvarianFunction.

1989–1990 SitePrincipalInvestigator,HerbertSingerCollaborativeResearchAwardatBethIsraelMedicalCenter: AnimalModelofPolycysticOvarySyndrome.

1989–1990 Co-PrincipalInvestigator,

Insulin Receptor Abnormalities in Polycystic Ovary Syndrome NIH-Grant#R01DK40605.

LEONIDPORETSKY,M.D.

9

1989–1995 SitePrincipalInvestigatorRobertoPopeEndocrinologyResearchFundatCabriniMedicalCenter:Roleofinsulinandinsulin-likegrowthfactorsinovarianfunctions

1992–1994 SitePrincipalInvestigator,

DiabetesLengthofStayReductionProject,UnitedHospitalFundofNewYork

1992–1994 SitePrincipalInvestigator, DiabetesandMetabolismUnitProject,

FanFoxLeslieR.SamuelsFoundationRESEARCH-RELATEDACTIVITIES:1987 Member, Special Review Committee Reproductive Disorders of Women National

InstituteofChildHealthandHumanDevelopment(NICHD)1991 Member,CooperativeSpecializedInfertilityCenterProgramPanel,NICHD,NIH1992 Member, Specialized Population Research Center site visit team, University of

California,SanDiego,NICHD,NIH1992 Reviewerofgrants,MedicalResearchCouncil,UnitedKingdom1994 ReviewerofGrants,InternationalScienceFoundation1987–present Reviewerofmanuscriptsforthefollowingjournals:

JournalofClinicalEndocrinologyandMetabolism MetabolismTransplantationObesityResearchFertility&Sterility

1996–present BoardofDirectors MetropolitanDiabetesSociety NewYork,NewYork1997–present ReviewerofGrants,EndocrineFellows’Foundation1997–2008 AdvisoryBoards:

NationalDiabetesEducationInitiative(Parke-Davis)NationalEndocrinologyConsultantsInitiative(Bayer)Women’sHealthInitiative(Parke-Davis)RosiglitazoneAdvisoryBoard(Smith-Kline/Beecham)BasalInsulinAdvisoryBoard(Hoechst-Marion-Roussel)NationalACTOSAdvisoryBoard(Lilly/Takeda)DiabetesConsultantPanelMember(Aventis)

2008–2012 EditorialBoard,JournalofClinicalEndocrinologyandMetabolism2008-2018 EditorialBoard,JournalofDiabetes

LEONIDPORETSKY,M.D.

10

2010–2014 EditorialBoard,InternationalScholarlyResearchNetworkEndocrinology EditorialBoard,WorldJournalofDiabetes2014 GuestEditor,EndocrineClinicsofNorthAmerica,specialissues, “Complicationsofdiabetes”and“Diabetesanditsassociatedconditions”.2015-present SeriesEditor,“Contemporaryendocrinology”,Springer,Inc.

KöhlerTSandMcVaryKT,Editors,“Contemporarytreatmentoferectiledysfunction:Aclinicalguide”,2nded,2016,Springer,Inc.ISBN-10:3319315854.

PacakKandTaïebD,Editors,“Diagnosticandtherapeuticnuclearmedicinefor neuroendocrinetumors”,2017,Springer,Inc.DOI10.1007/978-3-319-46038-3. WintersSJandHuhtaniemiIT,Editors,“Malehypogonadism:Basic,clinicaland therapeuticprinciples”,2nded,2017,Springer,Inc.DOI10.1007/978-3-319-53298-1.SELECTEDINVITEDLECTURESANDPANELS:

11th International Symposium on Immunology of Reproduction of the International CoordinationCommitteeforImmunologyofReproduction.Topic:Insulinandperoxisomeproliferators-activatedreceptor-γsignalinginthehumanovary:Basicmechanismandclinicalimplications.Varna,Bulgaria,June2-4,2006.PresentedbyDonnaSeto-Young,Ph.D.International SymposiumonPCOS inHarbinChina,August, 2006. Topic: Insulin andperoxisomeproliferators-activated receptor-γ signaling in the human ovary: Basic mechanism and clinicalimplications.PresentedbyDonnaSeto-Young,Ph.D.

GlobalHealthCareConference.Topic:Diabetes.NewYork,May22-24,2007.

SessionChair, “Androgenicdisorders inwomen,” the89thAnnualMeetingof theEndocrineSociety,Toronto,Canada,June2-5,2007.GuestExpert,“1stWorldCongressonInterventionalTherapiesforType2Diabetes,”NewYork,NewYork,September15-16,2008.VisitingProfessor,“CombinedAdult-PediatricEndocrineGrandRounds,”MattelChildrenHospitalatUCLA,DavidGeffenSchoolofMedicineatUCLA,California,September24,2008

GuestSpeaker,“ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,”Shanghai,China,May10-11,2012.

DistinguishedInternationalFaculty,“8thInternationalSymposiaonDiabetes2013”,Delhi,Kolkata,Chennai,Mumbai,India,January18-26,2013.

InvitedLecturer,AmericanAssociationofClinicalEndocrinologists(AACE)PhilippinesChapter,Cebu,Philippines,August1-3,2013.InvitedLecturer,TokyoMedicalandDentalUniversity,Tokyo,Japan,December10,2013.InvitedLecturer,DepartmentofMedicineGrandRoundsatMountSinaiMedicalCenter,“PCOSUpdate2014”,NewYork,January7,2014.

LEONIDPORETSKY,M.D.

11

InvitedLecturer,CombinedMKSCC/CornellEndocrineGrandRounds,“Insulinandtheovary:Update2014”,NewYork,January8,2014.InvitedLecturer,4thInternationalCongressofGynaecologyandObstetrics2016.Topic:InsulinandtheOvary:Update2016.Barcelona,Spain,May28-30,2016.SessionChair,“Polycysticovarysyndrome,”4thInternationalCongressofGynaecologyandObstetrics2016,Barcelona,Spain,May28-30,2016.InvitedLecturer,“Pathwaytowellness:Men’shealthpanelandhealthfair,”TheUnitedNationsStaffRecreationCouncilandSaluSWell-BeingNetwork,NewYork,NY,August29,2017.

PROFESSIONALSOCIETIES:1985 AmericanDiabetesAssociation1987 InternationalDiabetesFederation1987 AmericanAssociationfortheAdvancementofScience1988 TheEndocrineSociety1994 AmericanAssociationofClinicalEndocrinologists1996 MetropolitanDiabetesSociety,foundingBoardmemberBESTDOCTORSLISTINGS:NewYorkMagazineTheNewYorkTimesMagazineU.S.NewsandWorldReportCastleConnollyMedicalLimitedORIGINALPEER-REVIEWEDPUBLICATIONS:1. PoretskyL.Somepeculiaritiesofdiabetesmellitusinyoungobesepatients.InV.MenschikoffandV.

Spesivtseva,Eds.,ProblemsofDiabetology,Moscow,50-511977.

2. PoretskyL,SmithD,SeibelM,PazianosA,MosesAC,FlierJS.SpecificInsulinbindingsitesinhumanovary.JClinEndocrinolMetab59:809-811,1984.

3. Poretsky L, Moses A. Hypoglycemia associated with Trimethoprim/Sulfamethoxazole therapy.

DiabetesCare7:508-509,1984.

4. PoretskyL,GrigorescuF,MosesAC,FlierJS.DistributionandcharacterizationoftheinsulinandIGF-1receptorsinthehumanovary.JClinEndocrinolMetab61:728-734,1985.

5. PoretskyL,LeibowitzIH,FriedmanSA.Thediagnosisofmyocardialinfarctionbycomputerderivedprotocolinamunicipalhospital.Angiology36:165-170,1985.

LEONIDPORETSKY,M.D.

12

6. Poretsky L, Garber J, Kleefield J. Primary amenorrhea and pseudoprolactinoma in a patientwithprimary hypothyroidism: reversal of clinical, biochemical and radiologic abnormalities withlevothyroxine.AmJMed81:180-182,1986.

7. PepperGM,PoretskyL, Gabrilove JL,AritoneMM. Ketoconazole reverseshyperandrogenism in a

patient with insulin resistance and acanthosis nigricans. J Clin Endocrinol Metab 65:1047-1052,1987.

8. GatesGS,BayerS,SeibelM,PoretskyL,Flier JS,MosesAC. Characterizationof insulin-likegrowth

factorIbindingtohumangranulosacellsobtainedduringinvitrofertilization. JReceptorResearch7:885-902,1987.

9. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwith

AcquiredImmuneDeficiencySyndrome.AmericanJMed82:1035-1038,1987.10. PoretskyL,BhargavaG,KalinM. Regulationof the insulinreceptors in thehumanovary(Invitro

studies).JClinEndocrinolMetab67:772-778,1988.11. Poretsky L, Lesvescue L, Smith D, Seibel M, Pazianos A, Hurd JK, Aretz HT, Flier JS.

Hyperandrogenism in a patient with a granulosa cell tumor and polycystic ovarian disease:characteristicsofinvitrosteroidogenesis.TheJournalReproductiveMed33:377-381,1988.

12. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Theeffectsofexperimentalhyperinsulinemiaon

steroid secretion, ovarian 125-I-insulin binding and ovarian 125-I-insulin-like growth factor Ibindingintherat.Endocrinology122:581-585,1988.

13. SingerF,HorlickM,PoretskyL.Recoveryofbeta-cellfunctionpostpartuminapatientwithinsulin-

dependentdiabetesmellitus.NewYorkStateJournalofMedicine9:496-498,1988.14. BhargavaG,PoretskyL,DenmanH, JandorekR,MillerLK. Hormonallyactive long-termcultureof

humanovariancells:initialcharacterization.Metabolism38:195-196,1989.15. Singer F, Bhargava G, Poretsky L. Persistent insulin resistance after normalization of androgen

levelsinawomanwithcongenitaladrenalhyperplasia.JournalReproductiveMedicine34:921-922,1989.

16. Poretsky L, Bhargava G, Levitan E. Type I insulin-like growth factor receptors in human ovarian

stroma.HormoneResearch33:22-26,1990.17. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.

Metabolism39:161-166,1990.18. Zumoff B, Miller L, Poretsky L, Levit C. Miller E, Heinz U, Denman H, Jandorek R, Rosenfeld R.

Subnormalfollicular-phaseserumprogesteronelevelsandelevatedfollicular-phaseserumestradiollevelsinyoungwomenwithinsulindependentdiabetes.Steroids55:560-564,1990.

19. Novick D, Joseph H, Croxson S, Salsitz E, Wang G, Richman B, Poretsky L, Keefe J, Whimbey E.

Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitatedmethadonemaintenancepatients.ArchIntMed150:97-99,1990.

LEONIDPORETSKY,M.D.

13

20. Battan R, Mariuz P, Raviglione MD, Sabatini MT, Mullen MP, Poretsky L. Pneumocystitis cariniiinfection of the thyroid in a hypothyroid patient with AIDS: Diagnosis by fine needle aspirationbiopsy.JClinEndocrinologyMetab72:724-726,1991.

21. Poretsky L, Clemons J, Bogovich K. Hyperinsulinemia and human chorionic gonadotropin

synergisticallypromotethegrowthofovarianfollicularcystsinrats.Metabolism41:903-910,1992.22. GochuJ,PiperB,MontanaJ,ParkHS,PoretskyL.Lymphomaofthethyroidmimickingthyroiditisin

apatientwiththeAcquiredImmuneDeficiencySyndrome.JEndocrinolInvest17:279-282,1994.23. SorbaraLR,TangZ,CamaA,XiaJ,SchenkerE,KohanskiRA,PoretskyL,KollerE,TaylorSI,DunaifA.

Absenceof insulinreceptorgenemutations in three insulin-resistantwomenwithpolycysticovarysyndrome.Metabolism43:1568-74,1994.

24. Ramaprasad S, Poretsky L. Life-threatening hyponatemia due to the syndrome of inappropriate

secretion of antidiuretic hormone (SIADH) in a patient with Miller Fisher Syndrome. EndocrinePractice1:64-66,1995.

25. Rubio SI, Naha KK, Poretsky L. Coexistence of diabetes and phosphofructokinase deficiency.

EndocrinePractice2:100-102,1996.26. PoretskyL,ChandrasekherYA,GiudiceLC,BaiC,H-LLiu,RosenwaksZ. Insulinreceptormediates

inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1(IGFBP-1)productioninhumangranulosacells.JClinEndocrinolMetab81:493-496,1996.

27. PoretskyL,ChunB,LiuHC,RosenwaksZ.Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-like

growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with apotencysimilartoinsulin-likegrowthfactorI(IGF-I)andhigherthaninsulin.JClinEndocrinolMetab81:3412-3414,1996.

28. RubioSI,Sauer-PlewinskiT,SabatiniM,PoretskyL. Kikuchi’sdiseaseassociatedwithHashimoto’s

thyroiditis.JEndocrinolInvest19:136-137,1996.29. Stolarczyk R, Laufer I, Poretsky L. Absence of acanthosis nigricans in a patient with the Type B

syndromeofinsulinresistanceandpreexistingdiabetes.DiabetesCare19:885-886,1996.30. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized

patientswithdiabetes.DiabetesCare20:1553-1555,1997.31. StolyarczykR,RubioS,SmolyarD,Young I,PoretskyL.24hrurinary freecortisol inpatientswith

acquiredimmunedeficiencysyndrome.Metabolism47:690-694,1998.32. PoretskyL,PrettoZ,KoproskiJ.,Lengthofstayonadiabetesclusterunit.EndocrinePractice5:66-

68,1999.33. BogovichK, Clemons J,PoretskyL. Insulinhas a biphasic effect on the ability of human chorionic

gonadotropintoinduceovariancystsintherat.Metabolism48:995-1002,1999.34. FerrandoSJ,RabkinJG,PoretskyL.Dehydroepiandrosteronesulfate(DHEAS)andtestosterone:RelationtoHIVillnessstageandprogressionoveroneyear.JournalofAcquiredImmuneDeficiencySyndromesandHumanRetrovirology22:146-154,1999.

LEONIDPORETSKY,M.D.

14

35.DamarioM,BogovichK,LiuHC,RosenwaksZ,PoretskyL.SynergisticeffectsofIGF-Iandhumanchorionicgonadotropinintheratovary.Metabolism49:314-320,2000.36. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW,MathisenAL, SchneiderRL, ThePioglitazone001

StudyGroup. Pioglitazonehydrochloridemonotherapyimprovesglycemiccontrolinthetreatmentofpatientswithtype2diabetes.DiabetesCare23:1605-1611,2000.

37. PoretskyL, LesserM,BrillonD. Lackofpostprandial leptinpeaks inpatientswith type2diabetes

MelliltusDiabetes,ObesityandMetabolism3:105-111,2001.38. Poretsky L, Seto-Young D, Shrestha A, Dhillon S, Mirjany M, Liu, H-C, Yih M, Rosenwaks Z.

Phosphatidyl-inositol-3 (PI-3)-kinase-independent insulin action pathway(s) in the human ovary. JClinEndocrinolMetab86:3115-3119,2001.

39. Tolentino M, Ferenczi A, Ronen L, Poretsky L. Combination of gemfibrozil and orlistat in the

treatmentof combinedhyperlipidemiawithpredominanthypertriglyceridemia. EndocrinePractice8:3,208-212,2002.

40. SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgand250µgACTHstimulationtests

fortheevaluationofadrenalfunctioninpatientswithAIDS.Metabolism52:647-651,2003.41. Seto-YoungD,ZajacJ,LiuHC,RosenwaksZ,PoretskyL.Theroleofmitogen-activatedproteinkinase

ininsulinandinsulin-likegrowthfactorI(IGF-1)signalingcascadesforprogesteroneandIGF-bindingprotein-1productioninhumangranulosacell.JClinEndocrinolMetab88:3385-3391,2003.

42. ZinmanB,KahnSE,HaffnerSM,O’NeillMC,HeiseMA,FreedMI,ADOPTStudyGroup. Phenotypic

characteristics of GAD antibody-positive recently diagnosed patientswith type 2 diabetes inNorthAmericaandEurope.Diabetes53:3193-3200,2004.

43.SalehiM,HouldenH,SheikhA,PoretskyL.Thediagnosisofadrenalinsufficiencyinapatientwith

AllgrovesyndromeandanovelmutationintheALADINgene.Metabolism54:200-205,2005.

44. Seto-YoungD,PaliouM,Schlosser J,AvtanskiD,ParkA,PatelP,HolcombK,ChangP,PoretskyL.Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-likegrowthfactorbindingprotein-1(IGFBP-1)production.JClinEndocrinolMetab90:6099-6105,2005.

45. Seto-YoungD,LeonardiO,ParkA,HolcombK,SalehiM,ChangP,YihM,Rosenwaks Z, Poretsky L.

Hormonally active non-transformed human ovarian cell culture from oophorectomy specimens:methodsofdevelopmentandinitialcharacterization.HormoneResearch64:238-247,2005.

46. Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhineyM, Ferenczi A, Sison CP, Haller I, Rabkin J.

Endocrineeffectsoforaldehydroepiandrosterone(DHEA)inmenwithHIVinfection:Aprospectiverandomizeddouble-blindplacebo-controlledtrial.Metabolism55:858-870,2006.

47. BrillonDJ,SisonCP,SalbeAD,PoretskyL.Reproducibiltyofaglycemicresponsetomixed mealsintype2diabetesmellitus.HormoneandMetabolicResearch38:536-542,2006.

LEONIDPORETSKY,M.D.

15

48. KahnSE,ZinmanB,HaffnerSM,O’NeillMC,HeiseMA,KravitzBG,ADOPTStudyGroup.Obesityisamajordeterminantoftheassociationofc-reactiveproteinlevelsandthemetabolicsyndromeintype2diabetes.Diabetes55:2357-2364,2006.

49. KahnSE,HaffnerSM,HeiseMA,HermanWH,HolmanRR,ADOPTStudyGroup.Glycemicdurabilityofrosiglitazone,metformin,orglyburidemonotherapy.NEJM355:2427-2443,2006.

50. Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z,

Poretsky L. Interactions among peroxisome proliferator activated receptor-γ, insulin signalingpathways,andsterodogenicacuteregulatoryproteininhumanovariancells.JClinEndocrinolMetab92:2232-2239,2007.

51.MartinezR,PoretskyL.Casestudy.Insulin2:144-145,2007.52. MartinezR,PoretskyL.Casestudyresponse.Insulin2:190-191,200753. Gurevich Y, Poretsky L. Possible prevention of hungry bone syndrome by preoperative use of

pamidronate.Otolaryngology-HeadandNeckSurgery,138:403-404,2008.

54. Kahn SE, ZinmanB, Lachin JM,Haffner SM,HermanWH,HolmanRR, Kravitz BG, YuD,HeiseMA,AftringRP,VibertiG,ADOPTStudyGroup.Rosiglitazone-associatedfracturesintype2diabetes:ananalysisfromadiabetesoutcomeprogressiontrial(ADOPT).DiabetesCare31:845-851,2008.

55. PoretskyL,SongL,BrillonDJ,FerrandoS,ChiuJ,McElhineyM,FerencziA,SisonC,HallerI,RabkinJ.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.HormoneandMetabolicResearch41:244-249,2009.

56. KahnSE,HaffnerSM,VibertyG,HermanWH,LachinJM,KravitzBG,YuD,Paul,G,HolmanRR,ZinmanB,ADOPTStudyGroup. RosiglitazonedecreasesC-Reactiveproteintoagreaterextentrelativetoglyburideandmetforminover4yearsdespitegreaterweightgain.DiabetesCare33:177-183,2010.

57. ZinmanB,HaffnerSM,HermanWH,HolmanRR,LachinJM,Kravitz,BG,PaulG,JonesNP,AftringRP,VibertiG,KahnSE,ADOPTStudyGroup. Effectofrosiglitazone,metformin,andglyburideonbonebiomarkersinpatientswithtype2diabetes.JClinEndocrinolMetab95:134-142,2010.

58. HomelPD,KahnSE,JonesNP,NoronhaD,Beck-NielsenH,VibertiG;ADOPTStudyGroup;RECORD

SteeringCommittee.ExperienceofmalignancieswithoralglucoseloweringdrugsintherandomizedcontrolledADOPT(ADiabetesOutcomeProgressionTrial)andRECORD(RosiglitazoneEvaluatedforCardiovascular Outcomes and Regulationof Glycaemia in Diabetes) clinical trials. Diabetologia53:1838-1845,2010.

59. PatelP,PoretskyL,LiaoE.LackofeffectofsubtherapeuticvitaminDtreatmentonglycemic

andlipidparameters inType2diabetes: ApilotProspectiverandomizedtrial. JDiabetes2:36-40,2010.

60. ParikhG,VaradinovaM,SuwandhiP,ArakiT,RosenwaksZ,PoretskyL, Seto-YoungD. VitaminDregulatessteroidogenesisand insulin-likegrowth factorbindingprotein-1 (IGFBP-1)production inhumanovariancells.HormMetabRes42:754-757,2010.

LEONIDPORETSKY,M.D.

16

61. Seto-YoungD,AvtanskiD,ParikhG,SuwandhiP,StrizhevskyM,ArakiT,RosenwaksZ,PoretskyL.Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interferingwithandrogenbindingtoaromatase.HormMetabRes43:250-256,2011.

62. Seto-Young D, Avtanski D, VaradinovaM, Park A, Suwandhi P, Parikh G,Poretsky L. Differential

roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signalingpathwaysforprogesteroneproductioninhumanovariancells.HormMetabRes43:386-390,2011.

63. AbelevZ,SethA,PatelR,GoldsteinS,BogunM,PaliouM,SchlosserJ,Homel P, Busta A, Seto-Young

D, TranbaughR,Poretsky L. Continuous Insulin Infusion (CII) is associatedwith a reduced post-surgical lengthofstay(LOS),butnotthecomplicationrate, inpatientswithdiabetesmellitus(DM)undergoingCoronaryArteryBypassGraft(CABG).JEndocrInvest,34:770-774,2011.

64. Araki T, Varadinova M, Goldman M, Rosenwaks Z, Poretsky L, Seto-Young D. Rosiglitazone and

pioglitazone alter aromatase kinetic properties in human granulose cells. PPAR Research.doi:10.1155/2011/926438,2011.

65. Seth A, Sy V, Pareek A, Suwandhi P, Rosenwaks Z,Poretsky L, Seto-YoungD. Thiazolidinediones

(TZDs) affect osteoblast viability and biomarkers independently of the TZD effects on aromatase.HormMetabRes45:1-8,2013.

66. KimSJ,SyV,ArakiT,BabushkinN,HuangD,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.Total adiponectin, but not inflammatory markers CRP, TNF-α, IL-6 and MCP-1, correlates withincreasingglucoseintoleranceinpregnantChinese-Americans.JDiabetes6:360-368,2014.

67. Pittas AG, Dawson-Hughes B, Sheehan P, Rosen C, Ware JH, Knowler WC, Staten M, The D2dResearchGroup.RationaleanddesignofthevitaminDandtype2diabetes(D2d)Study:Adiabetespreventionstudy.DiabetesCare.37:3227-3234,2014.

68. Yubero-Serrano EM, Woodward M, Poretsky L. Vlassara H, Striker GE, AGE-Less Study Group.

Effects of sevelamer carbonate on advanced glycation endproducts and anti-oxidant/pro-oxidantstatus inpatientswithdiabeteskidneydisease. Clinical JournalAmSocietyNephrology,10(5):59-66,2015.

69. Avtanski D, Hirth Y, Babushkin N, Sy V, Sharma D,Poretsky L, Seto-Young D. In Vitro effects of

pioglitazone on the expression of components of Wnt signaling pathway and markers of bonemineralization.HormMetabRes48:468-475,2016.

70. Poretsky L, Islam J, Avtanski D, Lin YK, Shen YL, Hirth Y, LesserM, Rosenwaks Z, Seto-Young D.Reproductiveeffectsofirisin:Initialinvitrostudies.ReprodBiol,17(3):285-288,2017.

71. Seto-YoungD, AvtanskiD, Kim SJ, SyV, Liao EP, LiuG,Wan S, LesserM,Poretsky L. Insulin-likegrowth factor (IGF)-I, IGF-bindingprotein (IGFBP)-1, and fibroblast growth factor (FGF)21 serumlevels inChinesewomenwith andwithout gestational diabetes. ClinObstetGynecolReprodMed,3(5):1-4,2017.

72. SonmezH,KamboV,AvtanskiD,LutskyL,PoretskyL.Thereadmissionratesinpatientswithand

without diabetesmellitus at an urban teaching hospital. J Diabetes Complications 31 (12), 1681-1685,2017.

LEONIDPORETSKY,M.D.

17

73. TaylorJE,FishmanSL,MorrisM,KrymskayaM,GoldmanR,PoretskyL.Acaseofhyperthyroidisminapatientusingnutritionalsupplement“SurvivalShield”.EndocrinePractice,DOI:10.4158/ACCR-2018-0086,2018.

REVIEWARTICLES,BOOKCHAPTERSandEDITORIALS:1. Flier JS, Poretsky L. Insulin allergy and insulin resistance. In Fauci AS, Lichtenstein LM, Eds.,

CurrentTherapyinAllergy,ImmunologyandRheumatology,1985-1986.Publishers:B.C.DeckerandC.V.MosbyP.136-140,1985.

2. PoretskyL,KalinM.Thegonadotropicfunctionofinsulin.EndocrineReviews8:132-141,1987.3. PoretskyL,KalinM.Diabetesandovariandysfunction:whatistheconnection?TheFemalePatient

13:112-132,1988.4. Poretsky L. Insulin receptor - a potential target for pharmacological agents. Drug News and

Perspectives2:6,325-328,1989.

5. PoretskyL,MaranA,ZumoffB.EndocrinologicalandmetabolicmanifestationsofAIDS.MountSinaiJournalofMedicine57:236-241,1990.

6. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin resistant states.Endocrine Reviews 12:3-13, 1991. Reprinted in The Endocrine Pancreas, Insulin Action andDiabetes.ANegro-VilarandL.E.Underwood,Eds.EndocrineReviewMonographs,EndocrineSocietyPress,Bethesda,MD2:115-124,1994.

7. PoretskyL. Role of insulin resistance in thepathogenesis of thepolycystic ovaries syndrome. In:Ovarian Endocrinopathies. R. Schats, J. Schoemaker, Eds; ParthenonPublishing, London, 169-177,1994.

8. Poretsky L. Insulin resistance and hyperandrogenism: Update 1994. In The Endocrine Pancreas,

InsulinActionandDiabetes:A.Negro-VilarandL.E.Underwood,Eds.EndocrineReviewsMonograph;EndocrineSocietyPress,Bethesda,MD,2:125-129,1994.

9. Poretsky L, Piper B. Dual defect hypothesis of the polycystic ovaries syndrome. Obstetrics and

Gynecology84:613-621,1994.10. PoretskyL,CanS,ZumoffB.Testiculardysfunctioninhumanimmunodeficiencyvirusinfectedmen.

Metabolism,Vol44,7:946-953,1995.11. KoproskiJ,PrettoZ,PoretskyL.Hospitalmanagementofpatientswithdiabetesinpost-DCCTera.

PracticalDiabetology14:2-7,1995.

12. PoretskyL,PastorC.Physicianreviewersandconflictofinterest,Editorial.TheEndocrinologist:5:85-86,1995.

13. PoretskyL,CataldoN,RosenwaksZ,GuidiceL.Insulin-relatedovarianregulatorysysteminhealthanddisease.EndocrineReviews20:535-582,1999.

LEONIDPORETSKY,M.D.

18

14. PoretskyL.Polycysticovarysyndrome(bookreview).JClinEndocrinolMetab86:2402,2001.

15.BloomgardenZ,FutterweitW,PoretskyL.Useofinsulinsensitizingagentsinpatients withpolycysticovarysyndrome.EndocrinePractice7:279-286,2001.16. TolentinoM,Zweig,SB,PoretskyL.Polycysticovariansyndrome.In:“PrinciplesofDiabetes

Mellitus”,pp701-721,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.17. ZajacJ,ShresthaA,PoretskyL.Themaineventsinthehistoryofdiabetesmellitus.In:“Principlesof

DiabetesMellitus”,pp19-37,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.18. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Obesityinpolycysticovary

syndrome: Two diseases or one? Turkish Journal of Endocrinology and Metabolism 4:149-157,2003.

19. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Pathogenesisofpolycysticovarysyndrome:Whatistheroleofobesity?Metabolism53:358-376,2004.

20. LiaoEP,PoretskyL.Polycysticovarysyndromeanditsmetaboliccomplications.

In"ObesityandDiabetes",pp255-276.C.Mantzoros,Ed.,HumanaPress,Totowa,NJ,2006.21. PoretskyL.Polycysticovarysyndrome:Increasedorpreservedovariansensitivitytoinsulin?JClin

EndocrinolMetab91:2859-2860,2006.22. LevineP,KaplunJ,ShavelsonD,PoretskyL.Thepre-Charcotfoot:Anewclinicalentitytoprevent

Charcotjointdisease.PracticalDiabetology25:24-28,2006.23. AlfonsoB,LiaoEP,BustaA,PoretskyL.TheroleofvitaminDindiabetesmellitus—anew

fieldofknowledgepoisedforD-velopment.Diabetes/MetabolismResearchandReviews25:417-419,2009.

24. Zweig,SB,TolentinoMC,StrizhevskyM,PoretskyL.Polycysticovarysyndrome.In:

“PrinciplesofDiabetesMellitus”,pp515-530,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.25. ZajacJ,ShresthaA,PatelP,PoretskyL.Themaineventsinthehistoryof

diabetesmellitus.In:“PrinciplesofDiabetesMellitus”,pp3-16,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

26. BrassBJ,AbelevZ,LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp37-55,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

27. PoretskyL.PrefaceII.In:“PrinciplesofDiabetesMellitus”,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

28. RomeroCM,LiaoEP,ZumoffB,PoretskyL.Dehydroepiandrosterone(DHEA)inHuman

ImmunodeficiencyVirusInfection:PrognosticandTherapeuticAspects.In:“DHEAinHumanHealthandAging”,pp195-205.R.Watson,Ed.,CRCPress,BocaRaton,FL,2011.

29. Araki T, Abdallah R, Rosenwaks Z,Poretsky L. Achieving a successful pregnancy inwomenwithPCOS.EndocrinologyandMetabolismClinicsofNorthAmerica,40:865-894,2011.

30. AlfonsoB,PoretskyL,BustaA.RoleofVitaminDinthepathogenesisandtherapyoftype1

diabetesmellitus. In: “Type1Diabetes/Book3”,CPLiu,Ed.,InTechOpenAccessPublisher,Rijeka,Croatia,2011.

LEONIDPORETSKY,M.D.

19

31. PoretskyL.“StopthesovietizationofAmericanmedicine,”Op/Ed,Forbes.com,July3,2012.32.PoretskyL.Lookingbeyondovernutritionforcausesofepidemicmetabolicdisease.Proceedingsof

theNationalAcademyofSciencesoftheUnitedStatesofAmerica.39:15537-15538,2012.33.PoretskyL.ThesovietizationofAmericanmedicine:Notesfromthefrontlines.Journalof AmericanPhysiciansandSurgeons,18(2),2:50-54,2013.34.LiaoE,PoretskyL.Whyfocusoncomplications?EndocrinologyandMetabolismClinicsofNorth America,42:657-1014,2013.35. NandiA,PoretskyL.Diabetesandthefemalereproductivesystem.EndocrinologyandMetabolism

ClinicsofNorthAmerica,42:915-946,2013.36. LiaoE,BustaA,PareekA,PoretskyL.Newapproachtopreventingandtreatingdiabetes mellitus:Focusonadvancedglycationendproducts(AGE).In:“Frontiersinclinicaldrug

research-diabetesandobesity”,Atta-Ur-Rahman,FRS,Ed.,pp33-36,BenthamScience,TheNetherlands,2014.

37. LiaoEP,PoretskyL.Associatedconditions:Whyaretheyimportant?Endocrinologyand

MetabolismClinicsofNorthAmerica,43:1,xvii-xviii,2014.38. NandiA,ChenZ,PatelR,PoretskyL.Polycysticovarysyndrome.Endocrinologyand MetabolismClinicsofNorthAmerica,43:1,123-147,2014.39. NandiA,SinhaN,OngW,SonmezE,PoretskyL.IstherearoleforVitaminDinhuman

reproduction?HormMolBiolClinInvest,25(1):15-28,2016.

40. SonmezH,KamboV,TahaR,PoretskyL.Reducinghospitalreadmissionsinpatientswithdiabetes:Developingbetterstrategies.EndocrPract,22:9,1134-1136,2016.DOI:10.4158/EP161315.CO.

41. GoldmanR,ZajacJ,ShresthaA,PatelP,PoretskyL.Themaineventsinthehistoryofdiabetes

mellitus. In: “Principles ofDiabetesMellitus”, pp3-19, 3rd edition, L. Poretsky, Ed. Springer,NewYork,2017.

42. LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp43-55,3rdedition,

L.Poretsky,Ed.Springer,NewYork,2017.43. SoodM,ZweigS,TolentinoM,StrizhevskyM,PoretskyL.Polycysticovarysyndrome.In:

“PrinciplesofDiabetesMellitus”,pp659-677,3rdedition,L.Poretsky,Ed.Springer,NewYork,2017.44. AvtanskiD,PoretskyL.Phyto-polyphenolsaspotentialinhibitorsofbreastcancermetastasis.

MolecularMedicine,2018,inpress.45. SonmezH,AvtanskiD,NandiA,MabagosG,PoretskyL.Advancedglycationend-products(AGEs)

andcoronaryarterydisease(CAD)inpatientswithandwithoutdiabetesmellitus.Submitted.

LEONIDPORETSKY,M.D.

20

46. ColonD,GoldsteinS,PoretskyL.Resourcesfortransgenderpersons.In:“TransgenderMedicine–InterdisciplinaryApproach”.L.Poretsky,Ed.Submitted.

47. PaliouM,PoretskyL,HembreeW.Endocrinologyoftransgendercare—adults.In:“Transgender

Medicine–InterdisciplinaryApproach”.L.Poretsky,Ed.Submitted. BOOKS:1. Principlesofdiabetesmellitus,1stedition.L.Poretsky,editor.KluwerAcademicPublishing,Boston,

MA,2002.

2. Principlesofdiabetesmellitus,2ndedition.L.Poretsky,editor.Springer,NewYork,2010.3. Conciseguidetodiabetes.L.Poretsky,editor.Springer,NewYork,2012.

4. Principlesofdiabetesmellitus,3rdedition.L.Poretsky,editor.Springer,NewYork,2017.

5. Transgendermedicine-InterdisciplinaryApproach,1stedition.L.Poretsky,editor.Inpreparation.

ABSTRACTSPRESENTEDATNATIONALANDINTERNATIONALMEETINGS:1. Poretsky L, SmithD, SeibelM,Moses AC, Flier JS. Specific insulin receptors in the human ovary:

possible mediators of hyperandrogenism in insulin resistant states. Proceedings of the 23rdScientificMeetingontheMass.AffiliateAmericanDiabetesAssociation,Boston,Mass.,1984p.16.

2. PoretskyL,GrigorescuF,FlierJS.InsulinbutnotIGF-Ireceptorsarewidelydistributedinthe

humanovaries.Presentedatthe67thAnnualMeetingoftheAmericanEndocrineSociety,A814,p.204,1985.

3. SeibelMM,PoretskyL,GrigorescuF,MosesAC,FlierJS.Thedistributionofinsulinreceptorsinthe

human ovary. Presented at the 41st AnnualMeeting of the American Fertility Society, A76, p.42,1985.

4. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquired

immune deficiency syndrome. Presented at the 68th Annual Meeting of the American EndocrineSociety,A680,p.201,1986.

5. KalinM.PoretskyL,SeersD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquiredimmune deficiency syndrome. Presented at the 68th annual meeting of the American College ofPhysicians,A26April2-5,1987.

6. SingerF,HorlickM,PoretskyL.RecoveryofBeta-CellFunctionPostpartuminanInsulinDependent

Diabetic.Materialsofthe47thAnnualMeetingoftheAmericanDiabetesAssociation,A823June7-9,1987.

7. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Regulationofovarianinsulinreceptor,IGF-1receptors,andaromataseactivitybyexperimentalhyperinsulinemiainvivoClinicalResearch.35:401A,1987.

LEONIDPORETSKY,M.D.

21

8. PoretskyL,BhargavaG,KalinMF,WolfS,JimenesGJS,SolisOG.InvitroregulationofInsulin receptors in the human ovary. A686 70th Annual Meeting of the Endocrine Society; NewOrleans,1988.

9. Singer F, Poretsky L. Insulin Resistance persists after normalization of androgens in congenital

adrenalhyperplasia.48thAnnualMeetingoftheAmericanDiabetesAssociation,A579,NewOrleans,June11-14,1988.

10. PoretskyL, BhargavaG, KalinMF,Wolf S, JimenesGJS, SolisOG. In vitro regulation of insulin

receptorsinthehumanovary.13thInternationalDiabetesFederationCongress,Sydney,Australia,A002-015,1988.

11. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.

Presentedatthe71stAnnualMeetingoftheEndocrineSociety,SeattleWA,A894,1989.12. Poretsky L, Clemons J, Bogovich K. Effects of hyperinsulinemia on the induction of rat ovarian

follicular cysts by human chorionic gonadotropin. 73rd Annual Meeting of the Endocrine Society,WashingtonDC,A354,1991.

13. KoproskiJ,PrettoZ,PoretskyL.TheeffectoftheDiabeticUnitandtheDiabetesTeamon

the lengthof stayofpatientswithdiabetes in thehospital. Presentedat the54thAnnualAmericanDiabetesAssociationMeeting,NewOrleans,LA,A97,1994.

14. ChandrasekherYA,GiudiceLC,BaiC,LiuH-L,RosenwaksZ,PoretskyL.Insulinandinsulin-like

growthfactorI(IGF-I)inhibitIGFbindingproteinI(IGFBP-I)productionbyhumangranulosa-lutealcells(hGCs).AmericanFertilitySocietyMeeting,p.159,1994.

15. PoretskyL.Insulinresistanceandthepolycysticovarysyndrome.StraubPacificHealthFoundationSymposium,Honolulu,HI,November3-4,1994.

16. KoproskiJ,PrettoZ,PoretskyL. Theeffectsofdiabetesinitiativeinanacutecaresetting.GreaterNewYorkHospitalFoundation,Inc.AndUnitedHospitalFundofNewYork,1994AnnualSymposiumonHealthServicesResearch,NewYork,NY,November,1994.

17. PoretskyL, ChandrasekherYA,BaiC, LiuHC,RosenwaksZ, SiddleK,GiudiceL. Insulin and IGF-I

inhibit IGF binding protein I (IGFBP-I) production in human granulosa cells via their respectivereceptors.TheEndocrineSocietyMeeting,Washington,DC,P3-219,1995.

18. Koproski J, Pretto Z, Poretsky L. Effects of the multidisciplinary approach to patients with

diabetes mellitus in an acute care teaching hospital. American Diabetes Association Meeting,President’spostersession,Atlanta,GA,A596,1995.

19. ClarkC.R.,KimE.,ChandrasekherY.A.,MartinaN.A,PoretskyL,GiudiceL.D.Twodistinctisoforms

of IGFBP-1 are found in luteinized granulosa cell conditioned media from IVF patients. 10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-394,1996.

20. BogovichK.,Clemons,PoretskyL.Theeffectsofincreasingdosesofhumanchorionic

gonadotropinand insulinonovarianmorphologyandplasmasexsteroidconcentrations in therat.10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-317,1996.

LEONIDPORETSKY,M.D.

22

21. ChunB.,LiuH.C.,RosenwaksZ.,PoretskyL.Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-likegrowthfactorbindingproteinII(IGFBP-I)productioninhumangranulosecells(HGC) with the potency similar to IGF-I and higher than insulin. 10th International Congress ofEndocrinology,SanFrancisco,CA,P2-256,1996.

22. DamarioM.,Bogovich,LiuH.C,MandelL,RosenwaksZ,PoretskyL.Evidencethat

insulin-likegrowthfactorI(IGF-I)actssynergisticallywithhumanchorionicgonadotropin(hCG)fortheinductionoflargeovariancystsintherat.10thInternationalCongressofEndocrinology,SanFrancisco,CA,P1-303,1996.

23. BogovichK,WheelerB,RussellR,RosenwaksZ,PoretskyL.InductionofovariancystsintheZuckerrat.TheEndocrineSocietyMeeting,Minneapolis,MNP-389,1997.

24. Stolarczyk R, Rubio S, Young I,Poretsky L. 24 hr urinary free cortisol levels and plasma cortisol

responsestoACTHinAIDS.TheEndocrineSocietyMeeting,Minneapolis,MN,P-309,1997.25. YahampathN,PatelR,RaoR,FarkouhT,SalbeA,PoretskyL.Glycemicindexofamixedmeal(GIMM)

inNIDDM. 57thAnnualMeetingoftheAmericanDiabetesAssociation,A-1107,P289A,BostonMA,1997.

26. ManzoorA,LeeE,BrillonD,SalbeA,PoretskyL.Glycemicindexofamixedmeal(GIMM)in

type2DM.58thAnnualmeetingoftheAmericanDiabetesAssociation,0327,PA-84,Chicago,1998.27. Poretsky L, Brillon D. Circulating leptin levels do not change postprandially in patients with type2diabetesmellitus(DM)whoarenotoninsulintherapy.80thAnnualMeetingofthe EndocrineSocietyP3-389,P466,NewOrleans1998.28.SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgACTHstimulationtestsfor

the evaluation of adrenal function in patients with AIDS. 80th Annual Meeting of the EndocrineSociety,P2-389,P332,NewOrleans,1998.

29. Bogovich K, Bissada M, ReidWP, Wheeler BB, Rosenwaks Z, Poretsky L. Differences in ovarianresponses of lean and obese adult Zucker rats to prolonged stimulation by ubovulatory doses ofhumanchorionicgonadotropin(hCG):potentialeffectofhyperinsulinemiaonthegrowthofovariancysts.81stAnnualEndocrineSocietyMeeting,OR11-2SanDiego,1999.

30. PoretskyL,AndersonR,KynerJandMertenJ.Incidenceofhypoglycemia(fingerstickbloodglucose<50mg/dL)withmetformin/glyburide. Abstract 494. 60th AnnualMeeting of AmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.

31. Poretsky L,Mooradian A, Buse J, Kyner J andHenryD. Effect ofmetformin/glyburide tablets onlacticacidinpatientswithtype2diabetes.Abstract1523.60thAnnualMeetingofAmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.

32. PoretskyL,DhillonS,YihM,LiuHC,andRosenwaksZ.EvidenceforaPI-3kinaseindependent insulin action pathway in the ovary, Abstract #564, 82nd Annual Endocrine SocietyMeeting,Toronto,Canada,June21-24,2000.

33. Tolentino M, Poretsky L. Combination of Gemfibrozil and Orlistat in the treatment of severehypertriglyceridemia in a non-diabetic, non-obesemale. Annual Meeting, American Association ofClinicalEndocrinologists,Abstract#65,SanAntonio,Texas,May2-6,2001.

LEONIDPORETSKY,M.D.

23

34. ZajacJ,FleckmanA,PoretskyL.Mitralandtricuspidregurgitationwithmitralvalveprolapse

andcongestiveheartfailurecomplicatingGraves’disease.AnnualMeetingoftheAmericanAssociationofClinicalEndocrinologists,Abstract#49,SanAntonio,Texas,May2-6,2001.

35. PoretskyL,Seto-YoungD,ShresthaA,LiuH-C,YihM,RosenwaksZ.Humangranulosecells(HGC)possessPI-3kinase-independentinsulinactionpathway(s)whichregulateprogesteroneandIGFBP-1 production, Abstract #P2-392, 83rd Annual Meeting of the Endocrine Society, Denver, Colorado,June2-24,2001.

36. ZajacJ,BranovanD,SuslinaI,PoretskyL.Prevalenceofanti-thyro-peroxidaseAntibodies

(anti-TPO-Ab) in subjects exposed in childhood to Chernobyl fallout. Poster accepted for AnnualMeetingofAmericanAssociationofClinicalEndocrinologists,Chicago,IL,May1-5,2002.

37. Zajac J, Salehi M, Bloomgarden B, Cohen R, Tranbaugh R, Poretsky L. Glycemic control and thelength of stay after coronary artery bypass grafting (CABG). 62nd Annual Meeting of AmericanDiabetesAssociation,704-P,SanFrancisco,CA,June14-18,2002.

38. Salehi M, Gouller A, Poretsky L. Acute leukopenia as manifestation of severe thyrotoxicosis in a

patientwithGraves’disease.Poster#P3-650,EndocrineSociety84thAnnualMeeting,SanFrancisco,CA,June19-22,2002.

39.Seto-YoungD,ZajacJ,LiuHC,RosenwaksZ,PoretskyL.Mitogenactivatedproteinkinase(MAP-kinase) independent effect of insulin in human granulosa cells. 84th AnnualMeeting of theEndocrineSociety,P2-452,SanFrancisco,CA,June19-22,2002.

40. ZweigS,RabkinJ,FerrandoS,BrillonD,PoretskyL.EndocrineeffectsoforalDHEAadministration.

84thAnnualMeetingoftheEndocrineSociety,P1-399,SanFrancisco,CA,June19-22,2002.41. Bravo-Vera R,Poretsky L, Fleckman A. Primary hyperparathyroidism and nonmedullary thyroid

cancer. 12th Annual Meeting and Clinical Congress of the American Association of ClinicalEndocrinologists,Abstract49,SanDiego,CA,May14-18,2003.

42. SalehiM,Poretsky L. Challenging diagnosis of adrenocorticotropin insensitivity in a patientwith

Allgrove’s syndrome, 12th Annual Meeting and Clinical Congress of the American Association ofClinicalEndocrinologists,Abstract#62,SanDiego,CA,May14-18,2003.

43. FerencziA,SheikhA,PoretskyL,FleckmanA.Misleadingelevationsofurinaryfreecortisol

measurementsinthediagnosticevaluationofCushing’sSyndrome.12thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#48,SanDiego,CA,May14-18,2003.

44. SalehiM,PaparsenosA,FerencziA,VecchioJ,ThakurS,CohenB,TranbaughR,LesserM,Busta A,Poretsky L. The impact of glycemic control on the length of stay (LOS) after coronaryarterybypassgraftingsurgery (CABG). Abstract#2048-PO,AmericanDiabetes Association63rdScientificSession,NewOrleans,LA,June13-17,2003.

45. Seto-YoungD,SalehiM,ChidakelA,ZajacJ,YihM,ChangP,PoretskyL.Initialcharacterizationofa

short-termhumanovariancellculture.85thAnnualMeetingoftheEndocrineSociety,P1-692,Philadelphia,PA,June19-22,2003.

LEONIDPORETSKY,M.D.

24

46. Seto-YoungD,ZajacJ,SalehiM,KaplunJ,FeldmanD,Hung-ChingL,RosenwaksZ,PoretskyL.TheroleofmitogenactivatedproteinkinaseininsulinandIGF-1signalingcascadesfor progesteroneandIGFBP-1productioninhumangranulosecells.85thAnnualMeetingoftheEndocrineSociety,P3-33,Philadelphia,PA,June19-22,2003.

47. FerencziA,ChiuJ,SisonC,FerrandoSJ,BrillonD,RabkinJG,PoretskyL.Metabolicand

hormonaleffectsoforalDHEAinHIV+men.85thAnnualMeetingoftheEndocrineSociety,P3-615,Philadelphia,PA,June19-22,2003.

48. PaliouM,LiaoE,SchlosserJ,PoretskyL.Metformin-associatedlacticacidosis.13thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#37,Boston,MA,April28-May2,2004.

49. SheikhA,SchlosserJ,Bravo-VeraR,NarasimhanG,PoretskyL.FalselylowhemoglobinA1c

levelsinapatientwithdiabetesmellitus,hepatitisCandHIVinfection.Abstract#2405-PO,AmericanDiabetesAssociation64thAnnualMeeting,Orlando,Fl,June4-8,2004.

50. Seto-Young D, Leonardi O, Holcomb K, Kaplun J, Omry G, Park A, Levy E, SalehiM, Bravo-Vera R,

SheikhA,ChangP,PoretskyL. Characterizationofanon-transformedhumanovariancellculture:Regulationofsteroidogenesisbygonadotropinsand insulin. 86thAnnualMeetingof theEndocrineSociety,P1-250,NewOrleans,LA,June16-19,2004.

51. PaliouM,SchlosserJ,AbelevZ,PaparsenosA,Seto-YoungD,SalehiM,BustaA,PoretskyL.Impactof

intravenous insulin infusion (III) on length of stay (LOS) and post-operative complications in 438patientswithdiabetes(DM)undergoingcoronaryarterybypassgraft(CABG).86thAnnualMeetingoftheEndocrineSociety,P1-332,NewOrleans,LA,June16-19,2004.

52. ParkA,PoretskyL,HolcombK,ChangP,Seto-YoungD.Effectsofrosiglitazoneonhumanovarian

steroidogenesisandIGFBP-1productioninvitro.52ndAnnualMeetingSocietyforGynecologicInvestigation,Abstract#16,LosAngeles,CA,March2005.

53. KaplunJ,LiuL,PoretskyL.Erythrocytosisasapresentingfeatureofacromegaly.14thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#742,Washington,DC,May18-22,2005.

54. PaliouM,Schlosser J,PoretskyL. Situs inversus total isassociatedwithSR⎜ gene translocation to

AM chromosome in a 46 male. 14th Annual Meeting and Clinical Congress of the AmericanAssociationofClinicalEndocrinologists,Abstract#777,Washington,DC,May18-22,2005

55. Liu L, Kaplun J, Paliou M, Schlosser J,Poretsky L. Falsely low HgbA1c in patients with diabetes

mellitusandHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-418,SanDiego,CA,June4-7,2005.

56. Seto-YoungD,PaliouM,SchlosserJ,PatelP,ParkA,AvtanskiD,LatifW,BabarN,YeshouD,OmryG,

HolcombK,PoretskyL.Peroxisomeproliferatoractivatedreceptor-γ(PPAR-γ)inhumanovariancells:ItsroleinregulationofsteroidogenesisandIGFBP-1production.87thAnnualMeetingoftheEndocrineSociety,P3-564,SanDiego,CA,June4-7,2005.

57. PaliouM,SchlosserJ,KaplunJ,SisonC,FerrandoSJ,BrillonDJ,RabkinJG,PoretskyL.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-567,SanDiego,CA,June4-7,2005.

LEONIDPORETSKY,M.D.

25

58. Saliby A, Brass B, Seto-Young D, Tranbaugh R, Poretsky L. The effects of glucose-insulin- potassium(GIK)infusionontheoutomesofcoronaryarterybypassgraft.Abstract#2157- PO, AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.59. PaliouM, Schlosser J,AbelevZ, SalehiM,PaparsenosA,BustaA, LesserM,PoretskyL. Impact of

glycemic control with intravenous insulin infusion (III) or subcutaneous insulin (SCI) on post-operative complications in diabetic patients undergoing coronary artery bypass graft (CABG).Abstract#2569-PO,AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.

60. SongL,HeringBJ,PoretskyL.Clinicalcourseofapatientwithisletcelltransplant.15thAnnualMeeting and Clinical Congress of the American Association of Clinical Endocrinologists, Abstract#319,Chicago,IL,April26-30,2006.

61. Seto-YoungD, AvtanskiD,Poretsky L. Insulin and peroxisomeproliferators- activated receptor-γsignaling in the human ovary: Basic mechanism and clinical implications. 11th InternationalSymposium on Immunology of Reproduction of the International Coordination Committee forImmunologyofReproduction,Varna,Bulgaria,June2-4,2006.

62. AvtanskiD,KaplunJ,StrizhevskyM,ParkA,PatelP,KantorY,BrownMK,

DhillonS,MoosavyA,PangX,AkhtarMJ,GoldmanM,YeshouD,HolcombK,RosenwaksZ,Seto-YoungD, Poretsky L. Interactions among PPAR-γ, insulin signaling pathways and aromatase in humanovariancells.88thAnnualMeetingoftheEndocrineSociety,P1-397,Boston,MA,June24-27,2006.

63.AvtanskiD,ParkA,KaplunJ,StrizhevskyM,KantorY,HolcombK,PoretskyL,Seto-YoungD.Effectsofmitogen-activatedproteinkinase(MAPK)inhibitiononprogesteroneandinsulin-like

growthfactorbindingprotein-1(IGFBP-1)productioninhumanovariancells.88thAnnualMeetingoftheEndocrineSociety,P1-409,Boston,MA,June24-27,2006.

64. PatelP,Seto-YoungD,PoretskyL,LiaoEP.EffectsofvitaminDsupplementationintype2diabetes

mellitus.88thAnnualMeetingoftheEndocrineSociety,P2-506,Boston,MA,June24-27,2006.

65. SalibyAH,StachelMW,SantosEM,Seto-YoungD,ZonzseinJ,TranbaughR,PoretskyL.Theeffectofglucose-insulin-potassium infusion and rosiglitazone on the clinical outcome and the circulatinglevelsoffreefattyacidsinpatientsundergoingcoronaryarterybypassgrafting.88thAnnualMeetingoftheEndocrineSociety,P3-659,Boston,MA,June24-27,2006.

66. GurevichY,PoretskyL.Canpamidronatepreventhungrybonesyndromeafterparathyroidectomy?

16thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#393,Seattle,WA,April11-15,2007.

67. AvtanskiDB,StrizhevskyM,ParikhG,ArakiT,RosenO,DemetriC,GoldmanM,CadaqS, RosenwaksZ,PoretskyL,Seto-YoungD.Theeffectofthiazolidinedionesonestrogen productioninhumangranulosecells.89thAnnualMeetingoftheEndocrineSociety,P1-317, Toronto,Canada,June2-5,2007.68.SongL,Seto-YoungD,LiuL,PoretskyL.Lackofconsistenteffectofinsulin-likegrowthfactorI(IGF-

1)onplasminogenactivatorinhibitortype1(PAI-1)productioninculturedhumanaorticendothelialcells(HAEC).89thAnnualMeetingoftheEndocrineSociety,P3-389,Toronto,Canada,June2-5,2007.

69. MartinezRE,PoretskyL,LamA,KrymskayaM,BurkeG.Diabeteseducationforthedeaf: unexploredterritory.16thAnnualMeetingandClinicalCongressoftheAmericanAssociationof

LEONIDPORETSKY,M.D.

26

ClinicalEndocrinologists,Abstract#272,Seattle,WA,April11-15,2007.70. BernsteinG,PoretskyL,LamA,KrymskayaM,DeJesusJ,DoyleR,BurkeG,ToweM,WorthingtonB.

Culturally CompententDiabetes Education Program forDeaf Patients. 34th AnnualMeeting of theAmericanAssociationofDiabetesEducators,AbstractCQ01,St.Louis,MO,August1-4,2007.

71. AvtanskiDB,ParikhG,StrizhevskyM,FengY,PareekA,SinghJ,SinghN,PolskayaM,RosenwaksZ,

Seto-Young D, Poretsky L. Thiazolidinediones inhibit estrogen synthesis by interfering withandrogenbindingtoaromatase.90thAnnualMeetingoftheEndocrineSocietyMeeting,AbstractP2-44,SanFrancisco,CA,June15-18,2008.

72. ParikhG,ChlamtacN,RosenwaksZ,PoretskyL,Seto-YoungD.VitaminDreceptor(VDR)is

expressed inhumanovariancells, likelymediating theeffectsofVitaminDon testosterone (T)andprogesterone (P) production. 90th AnnualMeeting of the Endocrine SocietyMeeting, Abstract P2-468,SanFrancisco,CA,June15-18,2008.

73. Poretsky L, DeJesus J, Lam A, Krymskaya M, Mantha K, Burke G. The effects of diabetes self-

managementeducationonHbA1`Cindeafpatients.68thScientificSessionsoftheAmericanDiabetesAssociation,Abstract861-P,SanFrancisco,CA,June6-10,2008.

74. AbelevZ,SethA,PatelRR,GoldsteinS,BogunMM,HomelP,BustaA,PoretskyL.Intravenousinsulin

infusion(III),24hrpostoperativecapillarybloodglucose(CBG)andpatientage affect post-surgicallengthofstay(LOS)andcomplicationsinpatientswithdiabetesmellitus(DMundergoingcoronaryarterybypassgraft (CABG). 69thScientificSessionsof theAmericanDiabetesAssociation,Abstract692-P,NewOrleans,LA,June5-9,2009.

75. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,PoretskyL.

The effects of a diabetes education program on clinical outcomes in patients with diabetes. 69thScientificSessionsoftheAmericanDiabetesAssociation,Abstract911-P,NewOrleans,LA,June5-9,2009.

76. ArakiT,GoldmanM,VaradinovaM, JoshiP,ChaanineA,SethA,FengY,RosenwaksZ,PoretskyL,

Seto-Young D. The effects of thiazolidinediones (TZD) on aromatase enzyme kinetics in humangranulosecells.91stAnnualMeetingoftheEndocrineSociety,AbstractP3-268,Washington,DC,June10-13,2009.

77. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,

Poretsky L. The effects of a diabetes education program on clinical outcomes in patients withdiabetes.36thAnnualMeetingof theAmericanAssociationofDiabetesEducators,Abstract153019,AtlantaGeorgia,August5-8,2009.

78. SethAK,GajzerDC,SuwandhiP,FengY,KatoS,RomeroC,PatelR,RosenwaksZ,PoretskyL,Seto-YoungD.Thiazolidinediones(TZDs)InhibitBoneTurnover.92ndAnnualMeetingoftheEndocrineSociety,AbstractP2-184,SanDiego,CA,June19-22,2010.

79. CadagS,PatelR,KahanJ,LiaoEP,PoretskyL.Latentautoimmunediabetesinadults(LADA)with

hightitersofGAD65antibodiesbutlackoflong-terminsulindependence.92ndAnnualMeetingoftheEndocrineSociety,AbstractP3-560,SanDiego,CA,June19-22,2010.

LEONIDPORETSKY,M.D.

27

80. ParikhG,Mantha-ThalerK,AyinikalA,PandyaS,JoshiP,HomelP,PoretskyL.ActionforDiabetesEducationProgramandTreatment(ADEPT):AnoutreachprogramforSouthAsianpatientswithdiabetes.70thScientificSessionsoftheAmericanDiabetesAssociation,Abstract1032-P,Orlando,FL,June25-29,2010.

81. DeJesusJ,KrymskayaM,ToweM,PoretskyL.Diabetesself-managementeducationforthe

deaf population. 70th Scientific Sessions of the American Diabetes Association, Abstract 1039-P,Orlando,FL,June25-29,2010.

82. AlfonsoB,MedvedovskyB,RapoportD,ArakiT,DubrowA,PoretskyL. Useof hemodialysis in a

patient with hyperosmolar hyperglycemic state and rhabdomyolysis – case report and literaturereview.93rdAnnualMeetingoftheEndocrineSociety.AbstractPI-560,Boston,MA,June4-7,2011.

83. Suwandhi P, Pareek A, Sy V, Seth A, Kim SY, Branis N, Seto-Young D, Poretsky L. Effect of

Thiazolidinediones on Osteoblast Biomarkers. 93rd Annual Meeting of the Endocrine Society.AbstractPI-189,Boston,MA,June4-7,2011.

84. DeJesus J, Krymskaya M, Poretsky L. Diabetes Prevention and Management in Hispanic/Latino

Population:TheFriedmanDiabetesInstitute(FDI)Model.AnnualMeetingoftheAmericanDiabetesAssociation,Abstract2153-PO,SanDiego,CA,June24-28,2011.

85. KimSY,SyV,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.

The role of adiponectin in the pathogenesis of gestational diabetes (GDM) in Chinese Americans.ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,Shanghai,China,May10-11,2012.

86. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.

Decreased total andhighmolecularweight adiponectin are associatedwith gestationaldiabetes inChineseAmericans. 72ndAnnualMeetingof theAmericanDiabetesAssociation,Abstract2539-PO,Philadelphia,PA,June8-12,2012.

87. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto- YoungD.

Totaladiponectin,butnotTNF-α,IL-6orMCP-1,correlateswiththeincreasingglucoseintoleranceinpregnantChinese-Americanwomen. 94thAnnualMeetingof theEndocrineSociety. AbstractSUN-213,Houston,TX,June23-26,2012.

88. Spritzler J, Stein DS, Bilello J, Poretsky L, Pakes G, Mildvan D. Tumor necrosis factor-α soluble

receptor type II level is an independent predictor of HIV disease progression after 8 weeks in aclinical endpoint trial (ACTG 320) in advanced HIV infection. XIX International AIDS Conference,AbstractA-452-0015-03979,Washington,DC,July22-27,2012.

89. Kim SY, Sy V, Babushkin N, Tan D, Liao EP, Liu G, Wan S, Poretsky L, Seto-Young D. Unlike in

Caucasians,FGF-21andRBP4donotdifferinChinese-Americanwomenwithorwithoutgestationaldiabetes.95thAnnualMeetingof theEndocrineSociety,Abstract SAT-809,SanFrancisco,CA, June15-18,2013.

90. HirthY,BabushkinN,SyV,SethAK,PareekAS,LinYK,PoretskyL,Seto-YoungD.

ThiazolidinedioneeffectsonthemineralcontentandthecomponentsoftheWntsignalingpathwayin the human osteoblasts. 95th Annual Meeting of the Endocrine Society, Abstract SUN-214, SanFrancisco,CA,June15-18,2013.

LEONIDPORETSKY,M.D.

28

91. StrikerGE,Yubero-SerranoEM,SwamyS,ElliotSJ,CaiW,ChenX,McKeeE,,KalajA,KruckelmanF,

Tirri L, Mantha K, Rayfield EJ, Uribarri J, Harbord N, Tamler R, Parikh G, Busta A, Poretsky L,Woodward M, Vlassara H. Reversal of suppressed estrogen receptor α and anti-oxidant levels:Possiblebenefitsforcardiovasculardisease(CVD)indiabetickidneydisease (DKD). 95thAnnualMeetingoftheEndocrineSociety,Abstract80-LB,SanFrancisco,CA,June15-18,2013.

92. BustaA,PoretskyL,Yubero-SerranoE,WoodwardM,VlassaraH,StrikerGE.TheeffectofSevelamer

on oxidant stress and albuminuria in patients with type 2 diabetes and kidney disease: Arandomized, controlled study. 7th Annual Friedman Fellows Symposium at the 74th ScientificSessionsoftheAmericanDiabetesAssociation,SanFrancisco,CA,June13-17,2014.

93. OngEC,PatelR,PoretskyL.Anatypicalpresentationofpituitarysarcoidosis:Acasereport.16thInternational Congress of Endocrinology andTheEndocrine Society 96thAnnualMeeting, AbstractSAT-0707,Chicago,IL,June21-24,2014.

94. Striker GE, Yuberro-Serrano E, Poretsky L, Vlassara H. Control of oral advanced glycation

endproducts(AGEs)bysevelamercarbonateimprovesglucosemetabolismandalbuminuriainStage2-4diabetickidneydisease(DKD).16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractSAT-0988,Chicago,IL,June21-24,2014

95. IslamJR,Seto-YoungDLT,LesserM,RosenwaksZ,PoretskyL. Doesirisinhaveaneffectonfemale

reproductivefunction?Initialin-vitrostudies.16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractMON-0053,Chicago,IL,June21-24,2014.

96. KamboV.,WakimW.andPoretskyL. Readmissionrates forpatientswithsecondarydiagnosisof

diabetes are increased regardles of primary diagnosis. Endocrine Society 97th Annual Meeting,AbstractTHR-184,SanDiego,CA,March5-8,2015.

97. Kambo, V., Lutsky, L., Poretsky L. Extremely short (1day) length of stay (LOS) in patients withdiabetes(DM)isassociatedwithhighreadmissionrates(RR).75thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract1370-P,Boston,MA,June5-9,2015.

98. AvtanskiDB,HirthY,BabushkinN, SyV, SharmaD,PoretskyL, Seto-YoungDL. InVitroeffectsofpioglitazone on the expression of Wnt signaling pathway components and markers of bonemineralization.EndocrineSociety98thAnnualMeeting,Abstract,Boston,MA,April1-4,2016.

99. AvtanskiD,KuppusamyP,SonmezH,ShnayderV,WolfeA,PavlovVA,TraceyKJ,PoretskyL.Plasmalevelsofresistincorrelatewithadenylylcyclase-associatedprotein1(CAP1)indiet-inducedobesitymousemodel. EndocrineSociety99thAnnualMeeting,Abstract#SAT-573,Orlando,FL,April1-4,2017.

100. Sonmez H, Kambo V, Lutsky L, Poretsky L. The readmission rates in patients with and without

diabetes mellitus at an urban teaching hospital. 77th Annual Meeting of the American DiabetesAssociation,Abstract1352-P,SanDiego,CA,June9-13,2017.

101. AvtanskiD,GarciaA, CaraballoB,ThangeswaranP,Bianco J, LaviA,Marin S,RoncaC, PoretskyL.Resistin increases breast cancer cell motility and induces cellular mesenchymal reprograming.EndocrineSociety100thAnnualMeeting,Abstract#SAT-329,Chicago,IL,March17-20,2018.

LEONIDPORETSKY,M.D.

29

102. AvtanskiD,GarciaA,ThangeswaranP, CaraballoB, LaviA,Bianco J,Marin S,RoncaC, PoretskyL.

Resistininhibitsinsulinsignalinginadenylylcyclase-associatedprotein1(CAP1)-dependentmannerEndocrineSociety100thAnnualMeeting,Abstract#SUN-141,Chicago,IL,March17-20,2018.

U.S.PATENTS:1. PoretskyL.U.S.Patent#4,861,073Newspaperholder,1989.

2. PoretskyL, Seto-YoungD. Use of thiazolidinediones for partial inhibition of androgen binding to

aromatase.U.S.PatientApplicationNo.12/463,522.Patentpending,2009.OTHER:1. SilverR,PoretskyL, Flier JS. TreatmentofNecrobiosis LipoidicaDiabeticorum. JAmerMedAssoc

254:3,422-423,1985(Letter).2. Acknowledgment:Experimentalworkpublished inGrigorescuF, Flier JS,KahnCR. Defect in insulin

receptorphosphorylationinerythrocytesandfibroblastsassociatedwithsevereinsulinresistance. J.BiolChem259:15003-15006,1984.

3. Novic D,Poretsky L, KalinM. Thyroid-function tests in patients treatedwithmethadone. Clinical

Chemistry35:1807-1808,1989(Letter).4. PoretskyL.Specificity-spilloverphenomenoninthehumanovary.NEnglJMed,321:7,p.474,1989

(Letter).5. Acknowledgment:Helpfulcommentspublished inSingerF,TalaveraW,ZumoffB. Elevated levelsof

anotensin-coveringenzymeinpneumocystiscariniipneumonia.Chest95;803-806,1989.6. PoretskyL.Medicaidproposal.TheNewYorkTimes,July20,1990;pA26(Letter).7. PoretskyL.OvarianInsulin-likeGrowthFactors.AnnInternMed.117-:535,1992(Letter).

8. PoretskyL.ChoicesforPatients(letter),TheNewYorkTimes,November30,1993.9. PoretskyL.DiagnosticScale(letter).TheNewYorkTimes,June18,1994.10. Rodriguez G.Poretsky L. Toradol Instead of Tapazole (letter). American Journal ofHealth System

Pharmacy,Vol52:1098,1995.11. StolarczykR,LauferI,PoretskyL.ReplytoEriksson.DiabCare20:1045,1997(letter).12. PoretskyL.Purchase(shortstory).NovoyeRusskoeSlovo(NewRussianWord,RussianDaily Newspaper):p62,November,7,1997.13. PoretskyL.“ChanukahinNewYork”MetropolitanDiary,TheNewYorkTimes,January26,1998.14. PoretskyL.Interviewedfor“Populardrugfordiabetesisscrutinized”byDavidMorrow,The NewYorkTimes,March26,1999.

LEONIDPORETSKY,M.D.

30

15. PoretskyL.Chichikov’sList(letter)TheNewYorkTimes,April9,1999.16. PoretskyL.“Greatblueheron”(apoem).OutdoorMagazine,Fall2000,p.13.17. PoretskyL.“Thebearstanza”(apoem).TheRiverReporter,Jan4th-10thissue,2001.18. PoretskyL.“Runningdeer”(apoem).TheRiverReporter,May24,2001.19. PoretskyL.Interviewedfor“Bristol-Meyersfightstolockinpatients”byGardinerHarris,WallStreet

Journal,May21,2001.20. PoretskyL.“Businessisbusiness”,MetropolitanDiary,TheNewYorkTimes,October8,2001.21. PoretskyL.“Hareinthepark”(apoem).OutdoorsMagazine,p.75,October,2001.

22. Poretsky L. Interviewed for “Abbot pushes its Synthroid, but should it?” by Gardiner Harris,Wall

StreetJournal,July17,2002.

23. PoretskyL.“Anoutdooradventure”(apoem).RiverReporter,August15-21,2002.

24. PoretskyL.“Tofallinlove”(apoem).RiverReporter,February13-19,2003.25. PoretskyL.Interviewedfor“Inthetreatmentofdiabetessuccessoftendoesnotpay”.TheNewYork

Times,January11,2006.26. PoretskyL.Interviewedfor“$6milliongiftresurrectsabootcampfordiabetics”.TheNew YorkTimes,April2,2006.27. PoretskyL.Interviewedfor“Whatyourdoctorisn’tsaying”.Men’sHealth,p.177,November 2006.28. PoretskyL.“Bonus”,MetropolitanDiary,TheNewYorkTimes,December25,2006.29. PoretskyL.“Mother’shand”(apoem).JewishCurrents,May-June2007.30. PoretskyL.Interviewedfor“Victoriesoverdiabetes”.DailyNews,October28,2007.31. PoretskyL.Interviewedfor“BethIsraelMedicalCenterInauguratesTheGeraldJ.Friedman DiabetesInstitute.”MedicalUpdate8:4,December2007.32. PoretskyL.“IceCreamandTolstoy,”MetropolitanDiary,TheNewYorkTimes,December3, 2007.33. PoretskyL.Interviewedfor“Bedeviledbythesugarsickness,”TheNewYorkTimes,March2,2008.34. PoretskyL.Interviewedfor“Regulatorsscuttledrugfordiabetes,“TheWallStreetJournal, September24,2010.36. PoretskyL.“Choiceswemake,”MetropolitanDiary,TheNewYorkTimes,June27,2011.

LEONIDPORETSKY,M.D.

31

37. PoretskyL.Re:“Betteruseofmedicalrecordsisgoodasfarasitgoes,”LettertotheEditor,TheWallStreetJournal,September26,2011.

38. Poretsky L. Re:“At what age would it be appropriate to perform genetic testing for diabetes?”

Point/Counter,EndocrineToday,p.11,September2011.39. PoretskyL.Galleryexhibit:“Bemine…always”,anexhibitionoflovepoemsandphotos.Poem:“Your

Lips” by Leonid Poretsky and an art object by Leonid Poretsky and Lee Clayton. Alliance Gallery,Narrowsburg,NewYork,January28-February18,2012.

40. PoretskyL. Re:“Meetthemarriagekiller,”LettertotheEditor,TheWallStreet Journal,February8,

2012.41. PoretskyL.TheAGE-LessWay(onlinebookreview),Amazon.com,July23,2012.42. Poretsky L. The Jewish plot: A story. On line: http://jewishcurrents.org/the-jewish-plot-a-story-

16445,April15,2013.Inprint:“JewishCurrents”,pp40-42,Summer2013.43. Poretsky L. Re: “Physician, hear thyself—Why communicationmatters,” Letters to the Editor, The

WallStreetJournal,April20-21,2013.44. Poretsky L. Re: “Readmissions often aren’t culpable acts.” Letters to the Editor, TheWall Street

Journal,May20,2013.45. PoretskyL. Re: “TraditionalMedicareshouldbeallowedtocompete.” EducationUpdate,Vol.XXII,

No.3,pp14,January/February2017.46. PoretskyL.ConceptualArtEvent:“Thankyouforcoming.”DaciaGallery,NewYork,May20,2017.

VOLUNTEERING:January17-24,2015VolunteerPhysicianfortheUnitedStatesBobsledandSkeletonFederationEurope

CupSkeletonTeam.-SaintMoritz,Switzerland-Innsbruck,Austria

RECENTAWARDS:April2,2018 2018RosieAwardforadvancingdiversity;AmasMusicalTheatre49thSeasonBenefit

Event

LEONIDPORETSKY,M.D.

32

TRAINEES

Name

LevelofTrainee

RoleinTrainingandInclusive

DatesofTraining

TrainingVenue

Trainees’CurrentStatus/Employment

MarshaTolentino,MD

EndocrineFellow

07/01/99–06/30/01

MentorforClinicalResearch

PrivatePractice,Cebu,Phillippines

AnilShrestha,MD

EndocrineFellow

07/01/99–06/30/01


PrivateOffice,Miami,Florida

SusanZweig,MD

EndocrineFellow

07/01/00–06/30/02


Attending,NewYorkUniversity

JacekZajac,MD

EndocrineFellow

07/01/00–06/30/02


PrivatePracticeLombard,IL

AndreaFerenczi,MD

EndocrineFellow

07/01/01-06/30/03


PrivatePracticePeoria,AZ

MarziehSalehi,MD

EndocrineFellow

07/01/01-06/30/03


Attending,UniversityofCincinnati,OH

RafaelBravo-Vera,MD

EndocrineFellow

07/01/02-06/30/04


Novartis,MexicoCity

ArsalanSheikh,DO

EndocrineFellow

07/01/02-06/30/04


PrivatePracticeBaltimore,MD

MariaPaliou,MD

EndocrineFellow

07/01/03-06/30/05


Chief,Endocrine,MetropolitanHospital,NY

JonathanSchlosser,DO

EndocrineFellow

07/01/03-06/30/05


PrivatePractice,Suffern,NY

JuliaKaplun,MD

EndocrineFellow

07/01/04-06/30/06


PrivatePractice,Suffern,NY

LisenLiu,MD

EndocrineFellow

07/01/04-06/30/06


PrivatePractice,NewYorkCity

RamonE.Martinez,MD

EndocrineFellow

07/01/05-06/30/07


PrivatePractice,Miami,Florida

LiqunSong,MD

EndocrineFellow

07/01/05-06/30/07


PrivatePractice,Connecticut

YuriyGurevich,DO

EndocrineFellow

07/01/06-06/30/08


PrivatePractice,Suffern,NewYork

PariniPatel,MD

ECRIPFellow/EndocrineFellow

07/01/04-06/30/08


PrivatePractice,NewJersey

MarinaStrizhevsky,DO


07/01/05-06/30/09


PrivatePractice,NewYorkCity

ZinovyAbelev,MD

EndocrineFellow

07/01/07–06/30/09


PrivatePractice,NewYork

StefanCadag,DO

EndocrineFellow

07/01/08-06/30/10


Attending,MountSinaiBethIsrael

SagitZolotov,MD

EndocrineFellowResearchTrack

07/01/0506/30/10


PrivatePractice,Israel

GrishmaParikh,MD

ECRIPFellowFriedmanFellowEndocrineFellow

07/01/07–06/30/10


PrivatePractice,NewJersey

BiancaAlfonso,MD

ECRIPFellowEndocrineFellow

01/01/07-06/30/11


PrivatePractice,Miami,Florida

LEONIDPORETSKY,M.D.

33

Name

LevelofTrainee


DatesofTraining

TrainingVenue


TakakoAraki,MD

FriedmanFellowEndocrineFellow

07/01/08-06/30/11


Attending,KaiserPermanente,LosAngeles,CA

YunFeng,MD

EndocrineFellow

07/01/10-06/30/12


PrivatePractice,Connecticut

AmitSeth,MD

ECRIPFellowEndocrineFellow

07/01/09-06/30/12


PrivatePractice,Newark,NewJersey

AshutoshPareek,DO


07/01/10-06/30/13


PrivatePractice,Maryland

CarlaRomero,MD

EndocrineFellow

07/01/11-06/30/13


Attending,MountSinaiBethIsrael

RonakPatel,MD

EndocrineFellow

07/01/12-06/30/14


PrivatePracticeNewark,NewJersey

ZiJianChen,MD

EndocrineFellow

07/01/12-06/30/14


Attending,MountSinaiMedicalCenter

ErwynOng,MD

EndocrineFellow

07/01/13-09/01/14


PrivatePracticeNewMexico

HalisSonmez,MD

EndocrineFellow

07/01/13-09/01/14


Attending,LenoxHillHospital,NewYork

DimitarAvtanski,Ph.D.

Fellow-ThankstoScandinavia

2004-2008


Post-DoctoralFellow-JohnHopkins

DimaYeshou,MD

IMResident

2005


Endocrinologist,PrivatePractice,NewJersey

YevgeniyKantor,MD

IMResident

2006

MentorforClinicalResident

Attending,BrooklynHospital

MichaelGoldman,MD

EmpireClinicalResearchFellow

2007


Nephrologist–PrivatePractice,Queens,NY

GordonBurke,MD

MedicalStudent

2009


InternistBoston,MA

PrajeshM.Joshi,MD

IMResident

2009


Endocrinologist–PrivatePractice,Rogers,AR

MiroslavaVaradinova,Ph.D.

ResearchFellow

2009


Sofia,Bulgaria

DavidGajzer,MD

FriedmanFellowResearchFellow

2010


Fellow–Anesthesiology,Miami,FL

S.Kato,MD

IMResident

2010


PaulineSuwandhi,MD

FriedmanFellow

2010


Geriatrics,MontefioreHospital

DinaRapoport,MD

IMResident

2011


Endocrinologist,NYUHospital

So-YoungKim,MD

IMResident

2011


Endocrinologist,PrivatePractice

LEONIDPORETSKY,M.D.

34

Name

LevelofTrainee


DatesofTraining

TrainingVenue


NataliaBranis,MD

IMResident

2011


InternalMedicineSpecialist

NicoleBabushkin

ResearchAssistant

2012


MedicalSchoolStudent

VanessaSy-Po,MD

Volunteer

2012


FMLA–BirthofChild

YaelHirth

ResearchAssistant

2013


FMLA–BirthofChild

Yu-KueLin,MD

IMResident

07/01/13–06/30/14


FellowshipinEndocrinology–NIH

JulieIslam,MBBS

ResearchFellow/FriedmanFel`low

07/01/12–06/30/14


IMResident,MetropolitanHospital

MahmoudHassan,MD

ResearchFellow

01/01/14–09/01/14


Master’sProgram,JohnHopkinsUniversity,Baltimore,Maryland

HalisSonmez,MD ECRIPFellow 12/01/15–04/04/17


Endocrinologist,NYUQueensHospital,NY

SarahFishman,MD

EndocrineFellow

07/01/16–Present


Intraining

TrishaNewaz,DO

EndocrineFellow

09/27/2017–Present


Intraining

curriculum vitae leonid poretsky, m.d. · faculty member for the following problem based learning...

Documents